** Shares of Caplin Point Laboratories CAPL.NS up as much
as 3.7% to 1,137.90 rupees
** Co says Q2 profit jumps 26% to 1.16 bln rupees ($13.93
mln), while revenue from operations climbs 14.2%, outpacing a
7.4% rise in total expenses
** Q2 gross margin is 60%, up from 53.9% year ago, helped by
new product launches
** More than 168,800 shares trade by 1:06 p.m. IST, 2.1x
their 30-day avg
** Stock last up 2%; including session's gains, up ~54% YTD
vs 23% rise in Nifty pharma NIPT.NS index
($1 = 83.2725 Indian rupees)
(Reporting by Rama Venkat in Bengaluru)
((ramavenkat.raman@thomsonreuters.com; https://twitter.com/ramavenkat0607;))